Top Banner
CUTANEOUS MANIFESTATIONS OF SYSTEMIC DISEASES
42

Cutaneous manifestations of systemic disease

Oct 14, 2014

Download

Documents

Narinder Kumar
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Cutaneous manifestations of systemic disease

CUTANEOUS MANIFESTATIONS OF SYSTEMIC DISEASES

Page 2: Cutaneous manifestations of systemic disease
Page 3: Cutaneous manifestations of systemic disease

DUPUYTEN’S CONTRACTURE

• Fibromatous hyperplasia of the palmar aponeurosis, nodular thickening of fascia with associated flexion contractures of 1 or more digits.

• Familial,alcoholism, cirrhosis, epilepsy and diabetes mellitus,TB.

• Polyfibromatosis syndrome• Periarthritis of shoulder,chronic lung

disease,gout,trauma and ulnar nerve damage

Page 4: Cutaneous manifestations of systemic disease
Page 5: Cutaneous manifestations of systemic disease

DIABETIC DERMOPATHY(DIABETIC SHIN SPOTS)

• Shins, forearms, thighs, bony prominences

• Initial lesion oval dull red papule evolves slowly producing superficial scale, leaving an atrophic brownish scar.

Page 6: Cutaneous manifestations of systemic disease
Page 7: Cutaneous manifestations of systemic disease

THE DIABETICFOOT SYNDROME

• The cutaneous lesion is a plantar ulcer, often accompanied by soft tissue and bone infections which can require amputation.

• TRIGGERS include poorly fitting shoes, poor foot care, or overlooked foreign bodies, coupled with a structural foot deformity.

Page 8: Cutaneous manifestations of systemic disease

PATHOGENESIS OF DIABETIC FOOTSYNDROME

Page 9: Cutaneous manifestations of systemic disease

THERAPEUTIC GOALS

• The most important is optimal control of the diabetes mellitus

• Relieving pressure points and

• Avoiding or reducing callus formation

Page 10: Cutaneous manifestations of systemic disease

Association- 0.3 % of diabetic patients. Relatively asymptomatic lesions, F:M=3:1Characteristically found on the anterior and lateralsurfaces of the lower legs.

Page 11: Cutaneous manifestations of systemic disease

- Bullae appear spontaneously, usually on the extremities, especially the feet.- Heal in several weeks without significant scarring, although they may recur.

Page 12: Cutaneous manifestations of systemic disease
Page 13: Cutaneous manifestations of systemic disease

• Development of stiff, thick skin that resembles the changes in scleroderma

• Most apparent at acral sites, and may be associated with limited joint mobility (also known as cheirarthropathy) due to the abnormal collagen.

• The proposed mechanism is an increased cross-linking of collagen, known as non-enzymatic glycosylation (NEG), which produces stiffer collagen.

DIABETIC CHEIROARTHROPATHY

Page 14: Cutaneous manifestations of systemic disease
Page 15: Cutaneous manifestations of systemic disease
Page 16: Cutaneous manifestations of systemic disease
Page 17: Cutaneous manifestations of systemic disease
Page 18: Cutaneous manifestations of systemic disease
Page 19: Cutaneous manifestations of systemic disease

ACANTHOSIS NIGRICANS

• Cutaneous marker, most commonly of insulinresistance and less frequently of a malignancy.

• Hyperpigmented, hyperkeratotic, verrucous plaques that bestow a velvety texture on involved skin.

• Typically symmetric in distribution• Involves intertriginous areas, including the neck, axillae,

groin, antecubital and popliteal fossae, and umbilicus • Occasionally involves the oral, esophageal, pharyngeal,

laryngeal, conjunctival, and anogenital mucosae

Page 20: Cutaneous manifestations of systemic disease

INSULIN RESISTANCE–RELATED

OBESITY

ENDOCRINOPATHIES: acromegaly, cushing’s, hypo and hyperthyroidism, Polycystic ovarian disease (Stein-Leventhal syndrome)

MALIGNANCY-RELATED • Adenocarcinoma: gastric• Endocrine: phaeochromocytoma,testicular, thyroid,carcinoid• Melanoma, Sarcoma• Lung• Lymphomas • Other: cervical, urinary bladderDRUG-INDUCED: Testosterone, nicotinic acid, diethylstilbestrol, oral

contraceptives, triazinate, glucocorticoids, and with topical application of fusidic acid.

IDIOPATHIC• Familial• Nonfamilial

Page 21: Cutaneous manifestations of systemic disease
Page 22: Cutaneous manifestations of systemic disease

DIABETIC FINGER PEBBLES

• An exaggeration of the skin markings over the knuckles and on the dorsal aspect of the terminal phalanges.

• They are more cobblestoned than knuckle pads.

Page 23: Cutaneous manifestations of systemic disease

REACTIVE PERFORATING COLLAGENOSIS

Page 24: Cutaneous manifestations of systemic disease

SCLEROEDEMAAreas of induration frequently after infection, spontaneously clear in months or years.

Page 25: Cutaneous manifestations of systemic disease

CUTANEOUS FEATURES ASSOCIATED WITH DIABETES MELLITUS

• Infections• Peripheral vascular and small-vessel disease • Neuropathy • Pruritus• Necrobiosis lipoidica • Granuloma annulare variants • Perforating disorders • Xanthomas • Scleredema • Drug-related • Features of associated autoimmune disease

Page 26: Cutaneous manifestations of systemic disease
Page 27: Cutaneous manifestations of systemic disease
Page 28: Cutaneous manifestations of systemic disease
Page 29: Cutaneous manifestations of systemic disease

DIAMOND TRIAD

The combination of acropachy with

exophthalmos and pretibial myxedema.

Page 30: Cutaneous manifestations of systemic disease

PRETIBIAL MYXEDEMA

• Localized oedematous and thickened pretibial plaques

• 1-10% hyperthyroidism

• Erythema and slight edema are the early signs, with subsequent peau d'orange appearance as the degree of infiltration increases.

Page 31: Cutaneous manifestations of systemic disease

THYROID ACROPACHY

• Clubbing of fingers and toes in Grave’s disease associated with soft tissue swelling of hands and feet with periosteal new bone formation.

• A number of other causes, including bronchial neoplasia.

Page 32: Cutaneous manifestations of systemic disease

CUTANEOUS FEATURES RELATED TO ABNORMALITIES OF THYROID

HORMONE LEVELS (THYROTOXICOSIS)SKIN • Soft, smooth, velvety, warm, Palmar erythema, facial

flushing • Pruritus • Hyperpigmentation• Pretibial myxedema• May also be features of associated autoimmune

diseases, e.g. vitiligo, urticaria   SWEATING: Increased NAILS: Fast growth, Soft nails, koilonychia, distal

onycholysis,Thyroid acropachy HAIR: Fine thin hair, diffuse alopecia,Loss of pubic, axillary,

and facial hair,Loss of lateral eyebrowsORAL: Large tongue, gingival swelling, oral candidosis.

Page 33: Cutaneous manifestations of systemic disease
Page 34: Cutaneous manifestations of systemic disease

HERTOG’S SIGN

Page 35: Cutaneous manifestations of systemic disease
Page 36: Cutaneous manifestations of systemic disease

CUTANEOUS FEATURES RELATED TO ABNORMALITIES OF THYROID

HORMONE LEVELS (HYPOTHYROIDISM)SKIN • Pale, cold, scaly, wrinkled• Puffy edema of hands, face, and eyelids• Purpura and ecchymoses• Pruritus (due to xerosis or asteatotic eczema)• Ivory-yellow color (in part due to carotenemia)• Xanthomatosis (secondary to hyperlipidemia)SWEATING: DecreasedNAILS: Slow nail growth, brittle and striated nailsHAIR: Coarse hair, diffuse alopecia

Page 37: Cutaneous manifestations of systemic disease
Page 38: Cutaneous manifestations of systemic disease

ESTABLISH THE DIAGNOSIS AND RULE OUT DIFFERENTIAL DIAGNOSES

• PALPATE PURPURA

• CHECK TEMPERATURE and assess if patient is unwell

• Complete blood examination (CBC) platelets

• SKIN biopsy for HP&direct IF

Page 39: Cutaneous manifestations of systemic disease

D/D OF NONPALPABLE PURPURAI. PROCOAGULANT

DEFECT

A. Hemophilia

B. Anticoagulant use

C. Disseminated intravascular coagulation

D. Vitamin K deficiencyE. Hepatic insufficiency with

poor procoagulant synthesis

II. POOR DERMAL SUPPORT OF VESSELS

A. Actinic (senile) purpura

B. Glucocorticoid therapy, topical or systemic

C. Vitamin C deficiency (scurvy)

D. Systemic amyloidosis (light chain–related, some familial types)

E. Ehlers-Danlos syndrome (some types)

F. Pseudoxanthoma elasticum

Page 40: Cutaneous manifestations of systemic disease

IDENTIFY THE CAUSE

• pANCA• Streptococcal serology or throat swab

(especially in children)• Erythrocyte sedimentation rate (ESR), urea and

electrolytes (U&E), liver function tests (LFTs)OTHER INVESTIGATIONS• Findings on history including hepatitis serology,

rheumatoid factor, cryoglobulins, immunoglobulins, antinuclear factor (ANF), total complement levels and serum protein electrophoresis.

Page 41: Cutaneous manifestations of systemic disease

ASSESS THE EXTENT OF THE VASCULITIS

Further investigations should be directed toward

investigating relevant systems:

• RENAL – urinalysis looking for proteinuria and haematuria

• GASTROINTESTINAL – abdominal pain, gastrointestinal bleeding

• MUSCULOSKELETAL – nonerosive polyarthritis

• PULMONARY – pleural effusion

• CARDIAC – pericardial effusion.

Page 42: Cutaneous manifestations of systemic disease

MANAGEMENT

• General principles of management for vasculitis: Rest, elevation of the legs and compression hosiery.

• Systemic therapy indicated if the vasculitis is extensive, painful, ulcerating, or if there is renal involvement.

• The cause of the vasculitis should be managed as appropriate.